872 related articles for article (PubMed ID: 17196853)
21. Identification of a novel recombinant allele in three unrelated Italian Gaucher patients: implications for prognosis and genetic counseling.
Filocamo M; Bonuccelli G; Mazzotti R; Giona F; Gatti R
Blood Cells Mol Dis; 2000 Aug; 26(4):307-11. PubMed ID: 11042032
[TBL] [Abstract][Full Text] [Related]
22. Gaucher disease: functional expression of the normal glucocerebrosidase and Gaucher T1366G and G1604A alleles in Baculovirus-transfected Spodoptera frugiperda cells.
Choy FY; Wei C; Levin D
Am J Med Genet; 1996 Oct; 65(3):184-9. PubMed ID: 9240741
[TBL] [Abstract][Full Text] [Related]
23. Identification of two novel and four uncommon missense mutations among chinese Gaucher disease patients.
Choy FY; Humphries ML; Shi H
Am J Med Genet; 1997 Aug; 71(2):172-8. PubMed ID: 9217217
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of glucocerebrosidase mutations in the Israeli Ashkenazi Jewish population.
Horowitz M; Pasmanik-Chor M; Borochowitz Z; Falik-Zaccai T; Heldmann K; Carmi R; Parvari R; Beit-Or H; Goldman B; Peleg L; Levy-Lahad E; Renbaum P; Legum S; Shomrat R; Yeger H; Benbenisti D; Navon R; Dror V; Shohat M; Magal N; Navot N; Eyal N
Hum Mutat; 1998; 12(4):240-4. PubMed ID: 9744474
[TBL] [Abstract][Full Text] [Related]
25. Divergent phenotypes in Gaucher disease implicate the role of modifiers.
Goker-Alpan O; Hruska KS; Orvisky E; Kishnani PS; Stubblefield BK; Schiffmann R; Sidransky E
J Med Genet; 2005 Jun; 42(6):e37. PubMed ID: 15937077
[TBL] [Abstract][Full Text] [Related]
26. Clinical and molecular aspects of Gaucher disease in New Zealand.
Woodfield MJ; Woodfield DG; Winship IM
N Z Med J; 1997 Aug; 110(1050):316-9. PubMed ID: 9315031
[TBL] [Abstract][Full Text] [Related]
27. DNA analysis of an uncommon missense mutation in a Gaucher disease patient of Jewish-Polish-Russian descent.
Choy FY; Wei C; Applegarth DA; McGillivray BC
Am J Med Genet; 1994 Jun; 51(2):156-60. PubMed ID: 7916532
[TBL] [Abstract][Full Text] [Related]
28. DNA mutational analysis of type 1 and type 3 Gaucher patients: how well do mutations predict phenotype?
Sidransky E; Bottler A; Stubblefield B; Ginns EI
Hum Mutat; 1994; 3(1):25-8. PubMed ID: 8118463
[TBL] [Abstract][Full Text] [Related]
29. Phenotypic and genotypic heterogeneity in Gaucher disease type 1: a comparison between Brazil and the rest of the world.
Sobreira E; Pires RF; Cizmarik M; Grabowski GA
Mol Genet Metab; 2007 Jan; 90(1):81-6. PubMed ID: 16996765
[TBL] [Abstract][Full Text] [Related]
30. Molecular screening of Japanese patients with Gaucher disease: phenotypic variability in the same genotypes.
Kawame H; Maekawa K; Eto Y
Hum Mutat; 1993; 2(5):362-7. PubMed ID: 8257989
[TBL] [Abstract][Full Text] [Related]
31. Molecular analysis and clinical findings in the Spanish Gaucher disease population: putative haplotype of the N370S ancestral chromosome.
Cormand B; Grinberg D; Gort L; Chabás A; Vilageliu L
Hum Mutat; 1998; 11(4):295-305. PubMed ID: 9554746
[TBL] [Abstract][Full Text] [Related]
32. Impaired trafficking of mutants of lysosomal glucocerebrosidase in Gaucher's disease.
Schmitz M; Alfalah M; Aerts JM; Naim HY; Zimmer KP
Int J Biochem Cell Biol; 2005 Nov; 37(11):2310-20. PubMed ID: 15982918
[TBL] [Abstract][Full Text] [Related]
33. Identification of a 55-bp deletion in the glucocerebrosidase gene in Gaucher disease: phenotypic presentation and implications for mutation detection assays.
Mao R; O'Brien JF; Rao S; Schmitt E; Roa B; Feldman GL; Spence WC; Snow K
Mol Genet Metab; 2001 Mar; 72(3):248-53. PubMed ID: 11243731
[TBL] [Abstract][Full Text] [Related]
34. The identification of eight novel glucocerebrosidase (GBA) mutations in patients with Gaucher disease.
Orvisky E; Park JK; Parker A; Walker JM; Martin BM; Stubblefield BK; Uyama E; Tayebi N; Sidransky E
Hum Mutat; 2002 Apr; 19(4):458-9. PubMed ID: 11933202
[TBL] [Abstract][Full Text] [Related]
35. Gaucher disease with prenatal onset and perinatal death due to compound heterozygosity for the missense R131C and null Rec Nci I GBA mutations.
Goebl A; Ferrier RA; Ferreira P; Pinto-Rojas A; Matshes E; Choy FY
Pediatr Dev Pathol; 2011; 14(3):240-3. PubMed ID: 20946052
[TBL] [Abstract][Full Text] [Related]
36. Genotypic heterogeneity and phenotypic variation among patients with type 2 Gaucher's disease.
Tayebi N; Reissner KJ; Lau EK; Stubblefield BK; Klineburgess AC; Martin BM; Sidransky E
Pediatr Res; 1998 May; 43(5):571-8. PubMed ID: 9585001
[TBL] [Abstract][Full Text] [Related]
37. Analysis of the beta-glucocerebrosidase gene in Czech and Slovak Gaucher patients: mutation profile and description of six novel mutant alleles.
Hodanová K; Hrebícek M; Cervenková M; Mrázová L; Vepreková L; Zemen J
Blood Cells Mol Dis; 1999; 25(5-6):287-98. PubMed ID: 10744424
[TBL] [Abstract][Full Text] [Related]
38. [Phenotype and mutational spectrum in Tunisian pediatric gaucher disease].
Ben Turkia H; Riahi I; Azzouz H; Ladab S; Cherif W; Ben Chehida A; Abdelmoula MS; Caillaud C; Chemli J; Abdelhak S; Tebib N; Ben Dridi MF
Tunis Med; 2010 Mar; 88(3):158-62. PubMed ID: 20415187
[TBL] [Abstract][Full Text] [Related]
39. Molecular analysis of Gaucher disease: screening of patients in the Montreal/Quebec region.
Choy FY; Woo M; Der Kaloustian VM
Am J Med Genet; 1991 Dec; 41(4):469-74. PubMed ID: 1776640
[TBL] [Abstract][Full Text] [Related]
40. Analysis of the β-glucocerebrosidase gene in Turkish Gaucher disease patients: mutation profile and description of a novel mutant allele.
Karaca E; Kalkan S; Onay H; Aykut A; Coker M; Ozkinay F
J Pediatr Endocrinol Metab; 2012; 25(9-10):957-62. PubMed ID: 23426826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
